Back
Kraig Biocraft Laboratories, Inc. Vs. Rapt Therapeutics, Inc. Industry Stock Comparison
Sell
42
KBLB
Kraig Biocraft Laboratories, Inc.
Last Price:
$0.09
Seasonality Move:
7.61%
Sell
40
RAPT
Rapt Therapeutics, Inc.
Last Price:
$33.91
Seasonality Move:
-27.57%
Sell
42
Kraig Biocraft Laboratories, Inc. (KBLB)
is a Sell
Is Kraig Biocraft Laboratories, Inc. a Buy, Sell or Hold?
-
The current Kraig Biocraft Laboratories, Inc. [KBLB] share price is $0.09. The Score for KBLB is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
KBLB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Rapt Therapeutics, Inc. (RAPT)
is a Sell
Is Rapt Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Rapt Therapeutics, Inc. [RAPT] share price is $33.87. The Score for RAPT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
RAPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KBLB Stock Price Chart
What is Kraig Biocraft Laboratories, Inc.'s stock price today?
-
The Kraig Biocraft Laboratories, Inc. share price today is $0.09The current trend is relatively stagnant and KBLB is experiencing buying pressure, which is a positive indicator for future bullish movement.
RAPT Stock Price Chart
What is Rapt Therapeutics, Inc.'s stock price today?
-
The Rapt Therapeutics, Inc. share price today is $33.87Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RAPT is experiencing slight buying pressure.
KBLB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 50.68 | Buy |
| Chaikin Money Flow: | 819316 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.09 - 0.09) | Sell |
| Bollinger Bands (100): | (0.08 - 0.1) | Sell |
RAPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.53 | Buy |
| Relative Strength Index (14 RSI): | 51.15 | Buy |
| Chaikin Money Flow: | 79100 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.58 - 35.84) | Sell |
| Bollinger Bands (100): | (16.83 - 33.91) | Buy |
KBLB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.08 | Buy |
| 20-day SMA: | 0.09 | Buy |
| 50-day SMA: | 0.09 | Sell |
| 200-day SMA: | 0.09 | Sell |
| 8-day EMA: | 0.08 | Buy |
| 20-day EMA: | 0.09 | Buy |
| 50-day EMA: | 0.08 | Buy |
| 200-day EMA: | 0.06 | Buy |
RAPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35 | Sell |
| 20-day SMA: | 34.72 | Sell |
| 50-day SMA: | 31.71 | Buy |
| 200-day SMA: | 17.02 | Buy |
| 8-day EMA: | 31.84 | Buy |
| 20-day EMA: | 21.97 | Buy |
| 50-day EMA: | 11.45 | Buy |
| 200-day EMA: | 3.3 | Buy |
Kraig Biocraft Laboratories, Inc. Earnings Growth & KBLB Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rapt Therapeutics, Inc. Earnings Growth & RAPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.65 per share, and a decrease next year of $1.22 per share.
Kraig Biocraft Laboratories, Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rapt Therapeutics, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||